Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Miscellaneous | 12.07% |
| 3 | Energy | 11.62% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Financials | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVA
2076
DELISTED
Covanta Holding Corporation
CVA
| $1.49M | ﹤0.01% |
85,425
+38,975
| +84% | +$771K |
|
|
RSE
2077
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $1.49M | ﹤0.01% |
95,531
+73,152
| +327% | +$1.22M |
|
|
AKTX
2078
Akari Therapeutics
AKTX
$17.3M
| $1.49M | ﹤0.01% |
+77
| New | +$911K |
|
|
TAHO
2079
DELISTED
Tahoe Resources Inc
TAHO
| $1.48M | ﹤0.01% |
191,717
+94,733
| +98% | +$843K |
|
2080
Unilever
UL
$139B
| $1.48M | ﹤0.01% |
32,323
+9,224
| +40% | +$441K |
|
2081
PUT
Teekay
TK
$1.12B
| $1.48M | ﹤0.01% |
+50,000
| New | +$1.79M |
|
2082
PUT
Cracker Barrel
CBRL
$1.26B
| $1.47M | ﹤0.01% |
+10,000
| New | +$1.5M |
|
|
EGOV
2083
DELISTED
NIC Inc
EGOV
| $1.47M | ﹤0.01% |
83,009
+56,073
| +208% | +$1.02M |
|
2084
Radian Group
RDN
$4.85B
| $1.47M | ﹤0.01% |
92,280
-1,303,105
| -93% | -$23.3M |
|
2085
CALL
HF Sinclair
DINO
$17.1B
| $1.47M | ﹤0.01% |
+30,000
| New | +$1.43M |
|
2086
iShares Core S&P Mid-Cap ETF
IJH
$126B
| $1.46M | ﹤0.01% |
53,365
+45,320
| +563% | +$1.32M |
|
2087
United Bankshares
UBSI
$6.47B
| $1.46M | ﹤0.01% |
+38,387
| New | +$1.51M |
|
|
MIK
2088
DELISTED
Michaels Stores, Inc
MIK
| $1.46M | ﹤0.01% |
62,969
+5,097
| +9% | +$130K |
|
|
KKD
2089
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $1.45M | ﹤0.01% |
99,051
-634,318
| -86% | -$11.1M |
|
|
BCOV
2090
DELISTED
Brightcove, Inc.
BCOV
| $1.45M | ﹤0.01% |
294,244
+16,653
| +6% | +$94.2K |
|
|
KITE
2091
DELISTED
Kite Pharma, Inc.
KITE
| $1.45M | ﹤0.01% |
26,000
+6,682
| +35% | +$420K |
|
|
REV
2092
DELISTED
Revlon, Inc.
REV
| $1.45M | ﹤0.01% |
49,085
+18,884
| +63% | +$645K |
|
|
LEJU
2093
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
| $1.44M | ﹤0.01% |
25,830
+965
| +4% | +$59.5K |
|
|
CYT
2094
DELISTED
CYTEC INDS INC
CYT
| $1.44M | ﹤0.01% |
+19,507
| New | +$1.36M |
|
2095
Stewart Information Services
STC
$2.14B
| $1.44M | ﹤0.01% |
+35,189
| New | +$1.4M |
|
2096
Humana
HUM
$47.1B
| $1.44M | ﹤0.01% |
8,019
-221,248
| -97% | -$40.9M |
|
|
HAYN
2097
DELISTED
Haynes International, Inc.
HAYN
| $1.43M | ﹤0.01% |
37,896
+20,705
| +120% | +$847K |
|
2098
Mistras Group
MG
$606M
| $1.43M | ﹤0.01% |
+111,345
| New | +$1.78M |
|
|
SYNT
2099
DELISTED
Syntel Inc
SYNT
| $1.43M | ﹤0.01% |
31,535
-12,030
| -28% | -$527K |
|
|
COHR
2100
DELISTED
Coherent Inc
COHR
| $1.43M | ﹤0.01% |
26,070
-34,911
| -57% | -$2.04M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $4.58B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.